Opens in a new tab

Edwards Lifesciences v Meril (CFI, ORD_60760/2024, 15 November 2024)

Date15 November 2024
CourtCFI
DivisionMunich (DE) Local Division
Type of actionGeneric application
Registry referenceApp_57746/2024 · ORD_60760/2024
PartiesMeril Gmbh, Meril Life Sciences Pvt Ltd.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 15 November 2024 (UPC_CFI_15/2023, ACT_459987/2023), the Munich Local Division rejected the requests of Meril GmbH and Meril Life Sciences, defendants to Edwards Lifesciences’ infringement action on EP 3 646 825, for the Division to ask the European Commission about a possible competition investigation into Edwards and for leave to file further pleadings or reopen the hearing. Made after the oral hearing of 24 September 2024, the requests could not delay the decision announced for the very day of the order.

Question

Can a party, after the written procedure has closed and the oral hearing has taken place, have the Division seek information from the European Commission and reopen the proceedings?

Decision

No. The Court may disregard steps taken out of time (Rule 9.2 RoP), and further written pleadings may be allowed only on a reasoned request lodged before the judge-rapporteur closes the written procedure (Rule 36 RoP). The written procedure, the interim procedure and the oral hearing were over, with no leave for post-hearing submissions (II). Granting the requests would have jeopardised the date set for the decision (III). On substance, when asked at the hearing, Edwards had stated that the Commission was still at a fact-finding stage with no formal investigation opened, which Meril did not dispute (IV).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 73(2)(b)
Rules of Procedure
Rules 9.2, 36, 220.2 and 224.1(b)

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Generic application
Outcome (Dhenne Avocats summary)
Les demandes de Meril, présentées après l'audience, tendant à interroger la Commission européenne et à rouvrir les débats sont rejetées.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 646 825
A system comprising a prosthetic valve and a delivery catheter
recorded proprietor: Edwards Lifesciences Corp
Mentioned in the analysis (role not qualified)
Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.